Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey

Moeed, Abdul; Najeeb, Hala; Saleem, Arisha; Asghar, Muhammad Sohaib; Rafi, Hania Mansoor; Khattak, Abdullah Khan; Bilal, Zoha; Seboka, Binyam Tariku

doi:10.3389/fpubh.2022.911518

Cited by 14 publications

(24 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The main drivers for CBVH were fear about the side effects of booster vaccines [ 4 , 21 , 30 , 45 , 47 , 50 ], the severity of side effects associated with previous COVID-19 vaccines [ 26 , 29 , 31 , 34 ], concerns about adverse reactions to booster vaccines [ 6 , 52 ], adverse reactions experienced personally or among friends and family following previous COVID-19 vaccinations [ 5 , 7 , 30 , 52 ], and receipt of medical care following the COVID-19 vaccine primary doses [ 37 ]. Other studies reported uncertainty, risk, and safety concerns associated with booster doses [ 5 , 13 , 20 , 26 , 43 , 44 , 49 , 53 ].…”

Section: Resultsmentioning

confidence: 99%

“…In addition, previous research shows people in many other countries [ 4 , 5 , 6 ], especially in low-income countries, are hesitant to receive COVID-19 boosters, e.g., [ 7 , 8 ]. However, other researchers have found relatively low levels of COVID-19 booster vaccine hesitancy (CBVH) in developed [ 9 , 10 , 11 ] and developing countries, e.g., [ 12 , 13 ]. These conflicting results highlight the need for a systematic review of CBVH.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Limbu

Huhmann

2023

TropicalMed

View full text Add to dashboard Cite

As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle. This study systematically analyzed research that examined the predictors of COVID-19 booster vaccine hesitancy. A search of PubMed, Medline, CINAHL, Web of Science, and Scopus uncovered 42 eligible studies. Globally, the average COVID-19 booster vaccination hesitancy rate was 30.72%. Thirteen key factors influencing booster hesitancy emerged from the literature: demographics (gender, age, education, income, occupation, employment status, ethnicity, and marital status), geographical influences (country, region, and residency), adverse events, perceived benefit/efficacy, perceived susceptibility, perceived severity, prior history of COVID-19 infection, vaccination status, vaccination recommendations, health status, knowledge and information, skepticism/distrust/conspiracy theories, and vaccine type. Vaccine communication campaigns and interventions for COVID boosters should focus on factors influencing booster confidence, complacency, and convenience.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Limbu

Huhmann

2023

TropicalMed

View full text Add to dashboard Cite

show abstract

“…A recent study in China among the adult general population found that 76.8% of participants were willing to take the COVID-19 booster vaccine dose [ 23 ]. Another study among the Pakistani public reported 77.8% booster dose willingness [ 24 ]. A comparable favorable intention was stated by 84.5% of respondents in a recent cross-sectional study among Japanese medical students [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

et al. 2022

View full text Add to dashboard Cite

Objective: Vaccination hesitance for the COVID-19 booster dosage among hemodialysis patients is an important barrier in reducing morbidity and mortality linked to COVID-19 infection. Hence, this study aimed to explore the predictors of the third (booster) dose of COVID-19 vaccine intention among CKD patients on hemodialysis from the Kingdom of Saudi Arabia (KSA). Methods: This study was a multi-center cross-sectional study conducted at four dialysis centers in KSA from 13 February 2022 to 21 June 2022. The data was collected by the nephrologist in charge of the unit using a structured study questionnaire, which consisted of four parts; socio-demographic and clinical variables, questions about COVID-19 infection and subjective assessment of health state, COVID-19 booster dose vaccination intention and confidence in vaccines and preferences, and a health belief model. The study population consisted of 179 hemodialysis patients. Results: Participants in the study had conflicting health beliefs about their vulnerability to COVID-19 infection and the severity of the COVID-19 infection. Study participants expressed positive health beliefs about the advantages of the COVID-19 booster dose, and reported less perceived obstacles in receiving the vaccine. The influence of cues on action among the study population was high. A total of 140 (78.2%) hemodialysis patients expressed their intention to receive the COVID-19 booster dose. Patients who reported poor health in the self-rating of their health status had a substantially higher definite intention to take the COVID-19 booster dose, according to the chi-square test (11.16, df = 3, p = 0.01). There was a significant association between the constructs in the HBM model and COVID-19 vaccine (booster) intention. Marital status (OR = 1.67, CI 1.07–2.58) was found to be the strongest predictors of a definite intention to receive a COVID-19 booster dose. Confidence in the locally manufactured vaccine (OR = 0.33, CI 0.17–0.60), education (OR = 0.62, CI 0.41–0.93), and rating of health status (OR = 0.43 CI 0.25–0.74) were the strongest significant correlates of having no definite intention to take the COVID-19 vaccination. Conclusions: HBM constructs were found to be significantly associated with vaccination intention, which can be considered while planning policies to promote COVID-19 booster vaccination among hemodialysis patients. The study results could be utilized in drafting policies to improve COVID-19 booster dose vaccination uptake among hemodialysis population.

show abstract

“…First, due to convenience and snowball sampling, selection bias, such as the participation of fewer respondents with low Chinese/English language ability, may have affected the generalizability of the results. Second, the previous studies showed that determinants of receiving primary vaccination series and booster dose might be different ( 61 , 62 ); however, cluster analysis cannot be performed according to a different number of doses because this information was not included in the present study. Furthermore, the cross-sectional study design could not calculate the causal relationship between vaccine uptake and its determinants.…”

Section: Discussionmentioning

confidence: 92%

The determinants of COVID-19 vaccine uptake among migrants from 109 countries residing in China: A cross-sectional study

Chen

Lei

Wei

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundThe present study aimed to investigate the prevalence of COVID-19 vaccine uptake among foreign migrants in China and to explore the determinants of their vaccine uptake behavior.MethodsFrom June to October 2021, we used convenience and snowball sampling to recruit a sample of 764 participants from five cities in which the overwhelming majority of foreign migrants in China live. The chi-square (χ2) tests were used to examine vaccination distribution according to demographic characteristics. Multivariate logistic regression models visualized by forest plot were used to investigate the associations between significant determinants and vaccine uptake.ResultsOverall, the prevalence of vaccination rate was 72.9% [95% confidence interval (CI): 69.9–76.0%]. Migrants whose social participation was very active [adjusted odds ratio (AOR): 2.95, 95% CI: 1.36–6.50, P = 0.007] or had perceived COVID-19 progression prevention by the vaccine (AOR: 1.74, 95% CI: 1.01–3.02, P = 0.012) had higher odds of vaccination compared to those whose social participation was inactive or who did not have this perception. Migrants who perceived the vaccine uptake process as complex (AOR: 0.47, 95% CI: 0.27–0.80, P = 0.016) or were unsure of their physical suitability for the vaccine (AOR: 0.40, 95% CI: 0.24–0.68, P < 0.001) had lower odds of vaccination compared to those who did not have these perceptions. Furthermore, migrants from emerging and developing Asian countries (AOR: 2.32, 95% CI: 1.07–5.21, P = 0.04) and the Middle East and Central Asia (AOR: 2.19, 95% CI: 1.07–4.50, P = 0.03) had higher odds of vaccination than those from major advanced economies (G7) countries, while migrants from other advanced economic countries (OR: 0.27, 95% CI: 0.11–0.63, P = 0.003) had lower odds of vaccination than those from G7 countries.ConclusionIt may be beneficial to promote vaccine uptake among migrants by ensuring effective community engagement, simplifying the appointment and uptake process, and advocating the benefits and target populations of the COVID-19 vaccine.

show abstract

Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey

Cited by 14 publications

References 41 publications

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

The determinants of COVID-19 vaccine uptake among migrants from 109 countries residing in China: A cross-sectional study

Contact Info

Product

Resources

About